Skip to content

Clinical trials

Phase 2 Neurotoxicity Syndromes trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neurotoxicity Syndromes Phase: Phase 2 Country / region: United States Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20042
20081
20112
20121
20141
20191
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Terminated4
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center2
University of South Florida2
City of Hope Medical Center1
Columbia University1
Gerald Higa, PharmD.1
Gynecologic Oncology Group1
Jazz Pharmaceuticals1
Marcela V. Maus, M.D.,Ph.D.1
Radiation Therapy Oncology Group1
University of California, San Francisco1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neurotoxicity Syndromes12
Carcinoma, Ovarian Epithelial3
Ovarian Neoplasms3
Carcinoma, Non-Small-Cell Lung2
Lung Neoplasms2
Lymphoma2
Peripheral Nervous System Diseases2
Sarcoma2
Breast Neoplasms1
Burkitt Lymphoma1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.